Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway

por Guangshun, Sun, Guoqiang, Sun, Xin, Chen, Xiangyi, Kong, Wubin, Zheng, Zhitao, Li, Zhiying, Zheng, Hongyong, Cao, Chengyu, Lv, Yongxiang, Xia, Weiwei, Tang
Publicado 2022